申请人:Boy Kenneth M.
公开号:US20120184565A1
公开(公告)日:2012-07-19
Compounds of the formula (I) are provided, including pharmaceutically acceptable salts thereof:
which modulate β-amyloid peptide (β-AP) production, and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.
提供公式(I)的化合物,包括其药学上可接受的盐:这些化合物可以调节β-淀粉样肽(β-AP)的生成,可用于治疗阿尔茨海默病和其他受β-淀粉样肽(β-AP)生成影响的疾病。